Apollo Awaits First Proof-Of-Concept Data For Atopic Dermatitis Drug

 
• By Andrew McConaghie
  
Apollo Therapeutics is working with leading UK universities to translate research into novel drugs, but is also in-licensing biopharma assets. (Shutterstock)

More from Start-Ups & SMEs

More from Alimentary/Metabolic